This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Impetigo during breastfeeding

Authoring team

Impetigo during breastfeeding

Topical fusidic acid, hydrogen peroxide or mupirocin can all be used during breastfeeding.

  • is limited or no published evidence of use of these topical medicines during breastfeeding
    • there is limited systemic absorption and therefore negligible levels are expected in breast milk

If systematic antibiotics are required then flucloxacillin is safe in breastfeeding (2):

  • if penicillin allergic then all macrolide antibiotics can be used during breastfeeding with precautionary infant monitoring (3)

Clinical considerations

  • care should be taken to avoid direct contact between the infant and impetigo lesion(s) and treated area.
  • if lesions are on the breast or close to the nipple, it may not be possible to feed from that breast, although this would need thorough assessment
    • infant feeding support should also be sought in order to effectively maintain milk supply.
  • hands should be washed after applying topical preparations and before touching the infant.

Reference:

  1. NHS Specialist Pharmacy Service (March 21st 2024). Treating impetigo topically during breastfeeding
  2. NHS Specialist Pharmacy Service (February 16th 2024). Using penicillin antibiotics during breastfeeding
  3. NHS Specialist Pharmacy Service (March 21st 2024). Using macrolide antibiotics during breastfeeding

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.